GO:0004773 steryl-sulfatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004773 steryl-sulfatase activity is a molecular function that catalyzes the hydrolysis of steroid sulfates, such as dehydroepiandrosterone sulfate (DHEAS), to their unconjugated steroids and sulfate.
• The enzyme is also known as steroid sulfatase (STS) and arylsulfatase C, and it plays a key role in regulating the bioavailability of steroid hormones in tissues.
• Deficiency of steryl-sulfatase activity causes X-linked ichthyosis, while elevated activity is implicated in hormone-dependent cancers such as breast and prostate cancer.
• The catalytic mechanism involves a conserved cysteine residue that is post-translationally modified to formylglycine, essential for sulfate ester cleavage.
• Steroid sulfatase inhibitors are being developed as therapeutics for hormone-dependent diseases, with several compounds in clinical trials.
• Research on steryl-sulfatase activity uses enzyme assays, structural biology, and CRISPR-based gene editing to model loss- and gain-of-function in cells and animals.
Description
Steryl-sulfatase activity (GO:0004773) is a molecular function that removes sulfate groups from steroid sulfates, converting them into free steroids. This reaction is critical for the local production of active steroid hormones, such as estrogens and androgens, from circulating inactive precursors like DHEAS. The enzyme responsible, steroid sulfatase (STS), is a member of the sulfatase family and is widely expressed in tissues including the placenta, liver, and steroidogenic organs. Because of its role in hormone biosynthesis, steryl-sulfatase activity has become a target for therapeutic intervention in hormone-dependent cancers and other disorders. Understanding its mechanism, regulation, and genetic control is essential for researchers in endocrinology, oncology, and developmental biology.
steryl-sulfatase activity At A Glance
| GO ID | GO:0004773 |
|---|---|
| GO term | steryl-sulfatase activity |
| Ontology | molecular_function |
| Synonym | steroid sulfatase activity; arylsulfatase C activity; dehydroepiandrosterone sulfatase activity; steryl-sulfate sulfohydrolase activity |
| Major function | Hydrolysis of steroid sulfates to free steroids and sulfate |
| Reaction | 3-beta-hydroxyandrost-5-en-17-one 3-sulfate + H2O = 3-beta-hydroxyandrost-5-en-17-one + sulfate |
| Cofactor | Requires formylglycine (FGly) residue for catalysis |
| Localization | Endoplasmic reticulum membrane; also found in Golgi and plasma membrane |
| Substrates | DHEAS, estrone sulfate, pregnenolone sulfate, cholesterol sulfate |
What Is GO:0004773?
According to the Gene Ontology, steryl-sulfatase activity is defined as the catalysis of the reaction: 3-beta-hydroxyandrost-5-en-17-one 3-sulfate + H2O = 3-beta-hydroxyandrost-5-en-17-one + sulfate. In simpler terms, it is an enzyme activity that cleaves sulfate groups from sulfated steroids, releasing the free steroid and sulfate. This activity is synonymous with steroid sulfatase, arylsulfatase C, and dehydroepiandrosterone sulfatase, among other names.
Why Is steryl-sulfatase activity Important in Cell Biology?
Steryl-sulfatase activity is essential for the regulation of steroid hormone levels in target tissues, influencing processes such as reproduction, development, and cancer progression. By converting inactive sulfated steroids into active hormones, it amplifies local hormone action without affecting systemic levels. This makes it a critical node in endocrine signaling and a promising drug target.
• Regulates the bioavailability of estrogens and androgens in breast, prostate, and endometrial tissues.
• Deficiency causes X-linked ichthyosis, a skin disorder characterized by scaly skin.
• Overexpression is associated with hormone-dependent cancers, including breast and prostate cancer.
• Plays a role in placental estrogen synthesis during pregnancy.
• Involved in the metabolism of neurosteroids, affecting brain function.
• Target for therapeutic inhibitors in oncology and dermatology.
• Modulates cholesterol sulfate levels, impacting skin barrier function.
• Provides a model for studying sulfatase enzyme mechanism and formylglycine modification.
Molecular Mechanism of steryl-sulfatase activity
Substrate Recognition and Binding
In simple terms: The enzyme grabs onto a sulfated steroid molecule.
Steryl-sulfatase binds its substrates, such as dehydroepiandrosterone sulfate (DHEAS) and estrone sulfate, through a hydrophobic active site pocket that accommodates the steroid nucleus. The sulfate group is positioned near the catalytic residue for cleavage.
Catalytic Mechanism and Formylglycine
In simple terms: A special modified amino acid in the enzyme cuts the sulfate off the steroid.
The catalytic activity of steryl-sulfatase depends on a conserved cysteine residue that is post-translationally modified to formylglycine (FGly) by the formylglycine-generating enzyme. The FGly residue attacks the sulfate ester, leading to hydrolysis and release of the free steroid and sulfate.
Cofactors and Metal Ions
In simple terms: The enzyme needs a metal ion to work properly.
Steryl-sulfatase is a calcium-dependent enzyme; calcium ions are required for structural stability and catalytic activity. Other metal ions may also influence activity, but calcium is the primary cofactor.
Regulation of Enzyme Activity
In simple terms: The enzyme's activity can be turned up or down by various factors.
Steryl-sulfatase activity is regulated at multiple levels, including transcriptional control by hormones and growth factors, and post-translational modifications. Inhibitors such as curcumin and synthetic compounds can directly block its activity.
Key Genes Involved in GO:0004773 steryl-sulfatase activity
The following genes and proteins are directly involved in steryl-sulfatase activity or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STS | Encodes steroid sulfatase, the enzyme responsible for steryl-sulfatase activity | Mutations cause X-linked ichthyosis; overexpression in hormone-dependent cancers |
| SUMF1 | Encodes formylglycine-generating enzyme, required for STS activation | Defects cause multiple sulfatase deficiency |
| ARSA | Arylsulfatase A, another sulfatase with overlapping substrate specificity | Used in comparative studies of sulfatase mechanism |
| GALNS | N-acetylgalactosamine-6-sulfatase, a sulfatase family member | Model for understanding sulfatase structure-function |
| IDS | Iduronate-2-sulfatase, involved in glycosaminoglycan degradation | Provides insights into sulfatase catalysis |
| ESR1 | Estrogen receptor alpha, mediates estrogen signaling downstream of STS | Target in breast cancer research |
| AR | Androgen receptor, mediates androgen action following STS activity | Relevant in prostate cancer |
| CYP19A1 | Aromatase, converts androgens to estrogens, working with STS | Studied in hormone-dependent cancers |
| HSD17B1 | 17beta-hydroxysteroid dehydrogenase type 1, activates estrogens | Cooperates with STS in estrogen production |
| HSD3B2 | 3beta-hydroxysteroid dehydrogenase, inactivates steroids | Balances steroid hormone levels |
| SULT2A1 | Sulfotransferase that sulfates steroids, opposing STS | Regulates the pool of sulfated steroids |
| SULT1E1 | Estrogen sulfotransferase, sulfates estrogens | Modulates estrogen activity |
| NR0B1 | DAX1, nuclear receptor regulating steroidogenesis | May influence STS expression |
| NR5A1 | SF1, key regulator of steroidogenic genes | Controls expression of steroidogenic enzymes |
| IGF1 | Growth factor that can regulate STS expression | Linked to cancer progression |
| IL6 | Cytokine that modulates STS activity in inflammation | Implicated in cancer and inflammatory diseases |
| TNF | Tumor necrosis factor, affects STS expression | Studied in inflammation and cancer |
| VEGFA | Vascular endothelial growth factor, downstream of steroid signaling | Angiogenesis in tumors |
How Is steryl-sulfatase activity Regulated?
Steryl-sulfatase activity is regulated at the transcriptional level by hormones such as estrogens and androgens, as well as by growth factors and cytokines. Post-translational modification, particularly the conversion of cysteine to formylglycine, is essential for catalytic activity and is mediated by the formylglycine-generating enzyme. Additionally, the enzyme can be inhibited by endogenous steroids and exogenous compounds, including curcumin and synthetic inhibitors.
steryl-sulfatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STS | X-linked ichthyosis | STS knockout keratinocytes or mouse model |
| STS | Breast cancer | MCF-7 cells overexpressing STS |
| STS | Prostate cancer | LNCaP cells with STS inhibition |
| SUMF1 | Multiple sulfatase deficiency | SUMF1 knockout fibroblasts |
| STS | Neurosteroid imbalance | STS knockout mice for behavioral studies |
X-linked Ichthyosis
Deficiency of steryl-sulfatase activity due to mutations in the STS gene causes X-linked ichthyosis, a skin disorder characterized by dark, scaly skin. The lack of enzyme activity leads to accumulation of cholesterol sulfate in the epidermis, disrupting the skin barrier.
Hormone-Dependent Cancers
Elevated steryl-sulfatase activity is observed in breast, prostate, and endometrial cancers, where it contributes to the local production of active estrogens and androgens that promote tumor growth. Inhibitors of steroid sulfatase are being developed as therapies for these cancers.
Neurosteroid-Related Disorders
Steryl-sulfatase activity regulates the levels of neurosteroids such as DHEAS and pregnenolone sulfate, which modulate brain function. Altered activity has been implicated in mood disorders and neurodegenerative conditions, though the exact mechanisms remain under investigation.
From steryl-sulfatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of STS loss on steroid hormone levels? | STS knockout cell line (e.g., HEK293) |
| How does a specific STS mutation affect enzyme activity? | Point mutation knock-in of STS in cancer cells |
| Can we visualize STS localization in live cells? | Knock-in of fluorescent tag (e.g., GFP) at STS locus |
| What is the impact of STS overexpression on tumor growth? | Overexpression of STS in xenograft models |
| Which genes cooperate with STS in hormone synthesis? | CRISPR library screening in steroidogenic cells |
| How does STS inhibition affect global gene expression? | RNA-seq after STS inhibitor treatment |
How to Study the steryl-sulfatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Catalytic conversion of sulfated steroids | Inhibitor screening, kinetic studies |
| X-ray crystallography | Three-dimensional structure of enzyme | Active site analysis, inhibitor design |
| RNA-seq | Global gene expression changes | Pathway analysis after STS modulation |
| Western blot | Protein expression levels | Validation of STS knockout or overexpression |
| Immunohistochemistry | Tissue localization of STS | Cancer diagnostics |
| CRISPR knockout | Loss of gene function | Modeling X-linked ichthyosis |
| CRISPR knock-in | Introduction of specific mutations | Studying catalytic residues |
| Overexpression | Gain of function | Cancer cell proliferation assays |
Enzyme Activity Assays
Steryl-sulfatase activity is typically measured using fluorogenic or radiolabeled substrates such as 4-methylumbelliferyl sulfate or [3H]DHEAS. These assays quantify the release of sulfate or the formation of free steroid, allowing kinetic analysis and inhibitor screening.
Structural Biology
X-ray crystallography and cryo-EM have been used to determine the three-dimensional structures of sulfatases, including steryl-sulfatase, revealing the active site architecture and the formylglycine modification. These studies inform the design of specific inhibitors.
Gene Expression Analysis
Quantitative RT-PCR and RNA-seq are used to measure STS mRNA levels in tissues and cell lines, providing insights into transcriptional regulation. Western blotting and immunoblotting detect STS protein levels.
CRISPR-Based Functional Studies
CRISPR-Cas9 knockout, point mutation, and knock-in models enable precise manipulation of the STS gene to study its function in steroid metabolism and disease. These models are complemented by overexpression and reporter assays.
How CRISPR Can Be Used to Study GO:0004773 steryl-sulfatase activity
Knockout
CRISPR-Cas9 knockout of STS eliminates steryl-sulfatase activity, allowing researchers to study the consequences of enzyme loss in cell models, such as accumulation of sulfated steroids and changes in hormone-responsive gene expression.
Point Mutation
Introducing point mutations in the STS gene via CRISPR can mimic naturally occurring mutations found in X-linked ichthyosis or alter catalytic residues like the formylglycine site, providing insights into structure-function relationships.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous STS locus enables real-time imaging and proteomic analysis of the enzyme in its native context.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of STS can model the elevated enzyme activity seen in hormone-dependent cancers, facilitating studies on tumor growth and drug resistance.
How EDITGENE Supports steryl-sulfatase activity Research
Researchers studying steryl-sulfatase activity-related genes often need to determine whether a candidate gene is causally involved in steroid metabolism, cancer progression, or developmental disorders. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for steryl-sulfatase activity research.
Frequently Asked Questions About steryl-sulfatase activity
What is steryl-sulfatase activity?
Steryl-sulfatase activity is a molecular function that catalyzes the hydrolysis of steroid sulfates, such as DHEAS, to free steroids and sulfate.
What genes are involved in steryl-sulfatase activity?
The primary gene is STS, which encodes steroid sulfatase. Other genes like SUMF1 are required for its activation.
What diseases are associated with steryl-sulfatase activity?
Deficiency causes X-linked ichthyosis, while overexpression is linked to breast and prostate cancers.
How is steryl-sulfatase activity measured?
It is typically measured using enzyme assays with fluorogenic or radiolabeled substrates like 4-methylumbelliferyl sulfate.
What is the role of steryl-sulfatase in cancer?
It increases local estrogen and androgen production, promoting hormone-dependent tumor growth.
Can steryl-sulfatase activity be inhibited?
Yes, inhibitors such as curcumin and synthetic compounds have been shown to block its activity.
What is the catalytic mechanism of steryl-sulfatase?
It uses a formylglycine residue to cleave the sulfate ester bond, releasing the free steroid.
What are the synonyms for steryl-sulfatase activity?
Common synonyms include steroid sulfatase, arylsulfatase C, and dehydroepiandrosterone sulfatase.
How does steryl-sulfatase relate to X-linked ichthyosis?
Mutations in the STS gene cause a deficiency in steryl-sulfatase activity, leading to cholesterol sulfate accumulation in the skin.
What model systems are used to study steryl-sulfatase activity?
Cell lines, knockout mice, and CRISPR-edited models are commonly used.
Conclusion
Steryl-sulfatase activity (GO:0004773) is a critical enzymatic function that regulates steroid hormone bioavailability and has profound implications for human health and disease. From X-linked ichthyosis to hormone-dependent cancers, understanding its mechanism and regulation offers opportunities for therapeutic intervention. Advanced CRISPR tools and EDITGENE services empower researchers to dissect this pathway with precision.
References
- 1. Selcer KW et al.. 2002. Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells.. Steroids 67(10):821-6 PMID: 12231117
- 2. Miller WL. 2008. Steroidogenic enzymes.. Endocr Dev 13:1-18 PMID: 18493130
- 3. Ghosh D. 2005. Three-dimensional structures of sulfatases.. Methods Enzymol 400:273-93 PMID: 16399355
- 4. Anbar HS et al.. 2021. Steroid sulfatase inhibitors: the current landscape.. Expert Opin Ther Pat 31(6):453-472 PMID: 33783295
- 5. Ghosh D. 2023. Aromatase and steroid sulfatase from human placenta.. Methods Enzymol 689:67-86 PMID: 37802583
- 6. Dibbelt L et al.. 1986. Human placental steryl-sulfatase. Enzyme purification, production of antisera, and immunoblotting reactions with normal and sulfatase-deficient placentas.. Biol Chem Hoppe Seyler 367(12):1223-9 PMID: 3470015
- 7. Balasubramonian B et al.. 2023. The phytochemical curcumin inhibits steroid sulfatase activity in rat liver tissue and NIH-3T3 mouse fibroblast cells.. Steroids 191:109163 PMID: 36581086
- 8. Nussbaumer P et al.. 2004. Steroid sulfatase inhibitors.. Med Res Rev 24(4):529-76 PMID: 15170594
